Recently, malonyl CoA decarboxylase (MCD) has been identified as a key enzyme involved in the regulation of cardiac fatty acid oxidation.
最近，丙二酸辅酶a脱羧酶(MCD)已被确定为一个关键酶参与了心脏日常的脂肪酸氧化。
Rituximab may be effective in controlling MCD in a subset of patients.
美罗华可有效地控制麦当劳中的一个子集的患者。
Similar beneficial effects of MCD inhibition are seen in the in vivo pig heart subjected to a demand-induced ischemia.
丙二酸辅酶A脱羧酶（MCD ）抑制剂类似的有益效果还体现在受需求诱导的猪在体心脏方面。
Written as a general discussion of the subject matter, with illustrative examples provided and discussed in the case studies to show the breadth of application of MCD measurements.
作为一个主要内容的一般的讨论写，由于说明性的例子在案例研究过程中提供和讨论显示MCD尺寸的申请的宽度。
UCD has a good prognosis after surgery, while MCD often poorly responds to chemotherapy and has a relatively poor prognosis. New drugs and clinical trials are needed to improve the outcome of MCD.
UCD患者手术治疗的疗效和预后较好，MCD患者化疗效果欠佳，预后相对较差，需要尝试新的治疗手段。
UCD has a good prognosis after surgery, while MCD often poorly responds to chemotherapy and has a relatively poor prognosis. New drugs and clinical trials are needed to improve the outcome of MCD.
UCD患者手术治疗的疗效和预后较好，MCD患者化疗效果欠佳，预后相对较差，需要尝试新的治疗手段。
应用推荐